A Novel Naturally Occurring Tandem Promoter in Modified Vaccinia Virus Ankara Drives Very Early Gene Expression and Potent Immune Responses-Reference-Cited by-同舟云学术

A Novel Naturally Occurring Tandem Promoter in Modified Vaccinia Virus Ankara Drives Very Early Gene Expression and Potent Immune Responses

Published:2013-08-12 Issue:8 Volume:8 Page:e73511
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Wennier Sonia T.,Brinkmann Kay,Steinhäußer Charlotte,Mayländer Nicole,Mnich Claudia,Wielert Ursula,Dirmeier Ulrike,Hausmann Jürgen,Chaplin Paul,Steigerwald Robin

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference49 articles.

1. Vaccinia virus: a selectable eukaryotic cloning and expression vector;M Mackett;Proc Natl Acad Sci U S A,1982

2. Vaccinia virus: a tool for research and vaccine development;B Moss;Science,1991

3. Complications of smallpox vaccination, 1968;JM Lane;N Engl J Med,1969

4. Deaths attributable to smallpox vaccination, 1959 to 1966, and 1968;JM Lane;JAMA,1970

5. MVA and NYVAC as vaccines against emergent infectious diseases and cancer;CE Gómez;Curr Gene Ther,2011

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the transcriptomic profile of human monkeypox virus via CAGE and native RNA sequencing approaches;mSphere;2024-08-27

2. Exploring the Transcriptomic Profile of Human Monkeypox Virus via CAGE and Native RNA Sequencing Approaches;2024-05-01

3. Preclinical development of a first-in-class vaccine encoding HER2, Brachyury and CD40L for antibody enhanced tumor eradication;Scientific Reports;2023-03-30

4. Armored modified vaccinia Ankara in cancer immunotherapy;Viral Vectors in Cancer Immunotherapy;2023

5. Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels;Vaccines;2022-08-17